» Articles » PMID: 36185052

Soft Tissue Sarcoma: Correlation of Dynamic Contrast-enhanced Magnetic Resonance Imaging Features with HIF-1α Expression and Patient Outcomes

Overview
Specialty Radiology
Date 2022 Oct 3
PMID 36185052
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To investigate the value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) features for predicting hypoxia-inducible factor 1-alpha (HIF-1α) expression and patient outcomes in soft tissue sarcoma (STS).

Methods: We enrolled 71 patients with STS who underwent 3.0 Tesla (3.0T) MRI, including conventional MRI and DCE-MRI sequencing. The location, maximum tumor diameter, envelope, T2-weighted tumor heterogeneity, peritumoral edema, peritumoral enhancement, necrosis, configuration, tail-like pattern, bone invasion, and vessel/nerve invasion and/or encasement of the STSs were determined using conventional MRI images. The DCE-MRI parameters, including the volume transfer constant ( ), reflux rate ( ), volume fraction of extravascular extracellular matrix ( ), and time-signal intensity curve (TIC) type, of each lesion were independently analyzed by two observers. Independent samples -test, chi-square test, and Mann-Whitney U-test were performed to evaluate the differences in the MRI features between the two groups. The relationships between the DCE-MRI parameters and HIF-1α expression were analyzed using Spearman's correlation analysis. The Cox proportional hazards model and Kaplan-Meier method were used for survival analysis.

Results: Of the conventional MRI features, high heterogeneity, peritumoral enhancement, necrosis, and multilobulation of the T2-weighted tumor were prone to occur in the high-expression group. Of the DCE-MRI parameters, the high-expression group showed significantly higher (0.311±0.091 0.210±0.058 min), and values (0.896±0.656 0.444±0.300 min) than the low-expression group. No significant differences in TIC types and values were observed between the low- and high-expression groups (P>0.05). There were positive correlations between and values with HIF-1α expression (r=0.705, P<0.001; r=0.123, P<0.001, respectively). Receiver operating characteristic (ROC) analysis indicated high specificity (93.9%) of the value for predicting high expression of HIF-1α. The value provided the best performance in diagnostic sensitivity (84.2%). Survival analyses revealed that more than 50% necrosis, multilobulation, and values greater than 0.262 min were strongly associated with a higher risk of death.

Conclusions: Conventional MRI features and DCE-MRI parameters were significantly helpful in determining HIF-1α expression levels and predicting the overall survival (OS) of patients with STS.

Citing Articles

Enhanced magnetic resonance imaging features and management principles of low-grade myofibroblastic sarcoma of the breast: a case report.

Zhu M, Cheng W, Liu X, Ma L, Chen Y Gland Surg. 2025; 14(1):82-89.

PMID: 39958897 PMC: 11826251. DOI: 10.21037/gs-24-347.


Prediction of HIF-1α expression in endometrial carcinoma by enhanced T weighted angiography and dynamic contrast-enhanced magnetic resonance imaging.

Xie Z, Lin L, Ma C, Liu A Front Oncol. 2024; 14:1439229.

PMID: 39723370 PMC: 11668668. DOI: 10.3389/fonc.2024.1439229.


Applying dynamic contrast-enhanced MRI tracer kinetic models to differentiate benign and malignant soft tissue tumors.

Gao A, Wang H, Zhang X, Wang T, Chen L, Hao J Cancer Imaging. 2024; 24(1):64.

PMID: 38773660 PMC: 11107050. DOI: 10.1186/s40644-024-00710-x.


Primary synovial sarcoma on MRI - a case series and review of the literature.

Sedaghat M, Sedaghat S Pol J Radiol. 2023; 88:e325-e330.

PMID: 37576379 PMC: 10415809. DOI: 10.5114/pjr.2023.130048.


Multiparametric magnetic resonance imaging for radiation therapy response monitoring in soft tissue sarcomas: a histology and MRI co-registration algorithm.

Jung M, Bogner B, Diallo T, Kim S, Arnold P, Fullgraf H Theranostics. 2023; 13(5):1594-1606.

PMID: 37056570 PMC: 10086213. DOI: 10.7150/thno.81938.

References
1.
Semenza G . Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3(10):721-32. DOI: 10.1038/nrc1187. View

2.
Hoos A, Stojadinovic A, Mastorides S, URIST M, Polsky D, Di Como C . High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomas. Cancer. 2001; 92(4):869-74. DOI: 10.1002/1097-0142(20010815)92:4<869::aid-cncr1395>3.0.co;2-u. View

3.
Zhang M, Qiu Q, Li Z, Sachdeva M, Min H, Cardona D . HIF-1 Alpha Regulates the Response of Primary Sarcomas to Radiation Therapy through a Cell Autonomous Mechanism. Radiat Res. 2015; 183(6):594-609. PMC: 4800000. DOI: 10.1667/RR14016.1. View

4.
Li X, Wang Q, Dou Y, Zhang Y, Tao J, Yang L . Soft tissue sarcoma: can dynamic contrast-enhanced (DCE) MRI be used to predict the histological grade?. Skeletal Radiol. 2020; 49(11):1829-1838. DOI: 10.1007/s00256-020-03491-z. View

5.
Bansal A, Goyal S, Goyal A, Jana M . WHO classification of soft tissue tumours 2020: An update and simplified approach for radiologists. Eur J Radiol. 2021; 143:109937. DOI: 10.1016/j.ejrad.2021.109937. View